(Q41860167)

13 October 2017

Effects of milnacipran on binge eating - a pilot study (English)

1 reference

13 October 2017

1 reference

Shun'ichi Noma

1

1 reference

13 October 2017

Teruhisa Uwatoko

series ordinal

2

1 reference

13 October 2017

Haruka Yamamoto

series ordinal

3

1 reference

13 October 2017

Takuji Hayashi

series ordinal

4

1 reference

13 October 2017

language of work or name

English

0 references

publication date

1 February 2008

1 reference

Neuropsychiatric Disease and Treatment

13 October 2017

1 reference

13 October 2017

4

1 reference

13 October 2017

1

1 reference

13 October 2017

295-300

1 reference

Treatment of bulimia nervosa with sertraline: a randomized controlled trial

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515919

Use of reboxetine in bulimia nervosa: a pilot study

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515919

A rating scale for depression

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515919

The assessment of anxiety states by rating

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515919

Pharmacologic treatment of binge eating disorder

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515919

Treatment of classical Kaposi's sarcoma with gemcitabine

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515919

[123I] beta-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515919

Reboxetine in the treatment of bulimia nervosa: a report of seven cases

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515919

Pharmacotherapy of bulimia nervosa and binge eating disorder: longer-term outcomes

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515919

Milnacipran and selective serotonin reuptake inhibitors in major depression

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515919

Successful treatment with duloxetine in a case of treatment refractory bulimia nervosa: a case report

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515919

Milnacipran in the treatment of bulimia nervosa: a report of 16 cases

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515919

Venlafaxine treatment of binge-eating disorder associated with obesity: a series of 35 patients

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515919

Differential effects of milnacipran and fluvoxamine, especially in patients with severe depression and agitated depression: a case-control study

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515919

A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515919

Antidepressant efficacy and tolerability of milnacipran, a dual serotonin and noradrenaline reuptake inhibitor: a comparison with fluvoxamine

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515919

Fluvoxamine in prevention of relapse in bulimia nervosa: effects on eating-specific psychopathology.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515919

Aetiopathogenesis and pathophysiology of bulimia nervosa: biological bases and implications for treatment

18 August 2018

1 reference

PubMed

12 December 2020

Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid from bulimic patients with frequent binge episodes

1 reference

PubMed

12 December 2020

1 reference

12 December 2020

A self-rating scale for bulimia. The 'BITE'

1 reference

PubMed

12 December 2020

Identifiers

DOI

10.2147/NDT.S2505

1 reference

13 October 2017

1 reference

13 October 2017

PubMed publication ID

18728825

1 reference